The group’s principle activities include discovery, development, and commercialization of small molecule and protein therapeutics for the medical industry. The group’s products include RAGE Antagonists, Rage Fusion Proteins, Glucokinase Activators, PTP1B Inhibitors and Smallpox Anti-virals. The group operates from United States.
